Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 176 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria

 		Uncomplicated Plasmodium Falciparum Malaria Phase3 Congo, The Democratic Republic of the
Côte D'Ivoire
India
Mali
Niger
View All
 NCT05842954

Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP Materials

 		Multiple Sclerosis Switzerland NCT05301907

Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years

 		Relapsing Multiple Sclerosis Austria NCT05776888

Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts

 		Allergy, Peanut Phase2 United States NCT05432388

[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake

 		Neoplasms Phase1, Phase2 Austria
France
Netherlands
Spain
United Kingdom
United States
View All
 NCT03872778

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

 		Relapsing-Remitting Multiple Sclerosis Phase4 Canada
United States 		NCT05090371

Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation

 		Hidradenitis Suppurativa France NCT06444087

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

 		Age-Related Macular Degeneration Phase2 United Kingdom NCT05230537

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria

 		Uncomplicated Plasmodium Falciparum Malaria Phase2 Côte D'Ivoire
Ghana
Kenya
Uganda
View All
 NCT05750628

A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea

 		Graft-versus-Host Disease Korea, Republic of NCT05621733